Abstract
Objective HIV infection is associated with impaired cognition, and as individuals grow older, they may also experience age-related changes in mental abilities. Computer-based cognitive training (CCT) and transcranial direct current stimulation (tDCS) have both shown promise in improving cognition. This study evaluated the acceptability of CCT and tDCS to older adults with HIV-associated neurocognitive disorder, and assessed their impact on reaction time, attention, and psychomotor speed.
Methods In a single-blind randomized study, 46 individuals with HIV-associated mild neurocognitive disorder completed neuropsychological measures and six 20-minute training sessions, receiving (1) CCT with active tDCS; (2) CCT with sham tDCS, or (3) watching educational videos with sham tDCS. Immediately after training and again one month later, participants completed follow-up assessments. Outcomes were evaluated via repeated measures mixed effects models.
Results Participant ratings of the intervention were positive. Effects on reaction time were not significant, but measures of attention and psychomotor speed suggested positive effects of the intervention.
Conclusion Both CCT and tDCS were well accepted by older persons with HIV infection. CCT and tDCS may improve cognitive in affected individuals.
Significance CCT and tDCS may be useful in treating HIV-associated neurocognitive disorders.
Highlights
Current treatment options for HIV-associated neurocognitive disorders (HAND) in persons 50 or older are limited.
Both transcranial direct current stimulation (tDCS) and computer-delivered cognitive training (CCT) may have positive effects on cognition.
This study showed that both cognitive training and transcranial direct current stimulation were acceptable to older persons with HAND and were associated with limited evidence of improved objective and subjective cognitive function.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03440840
Funding Statement
This work was supported by a grant from the US National Institutes on Aging to Dr. Ownby (grant R21AG056256).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This protocol was approved by the Institutional Review Board of Nova Southeastern University (protocol number 2017-410).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.